FDA Approved: DIFLUPREDNATE — Original Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves Mylan's original generic application for difluprednate ophthalmic 0.05% (DIFLUPREDNATE) for reduction of ocular inflammation and pain following cat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Inflammation

Drugs mentioned

• DIFLUPREDNATE (difluprednate)

Snippet

ORIG AP for DIFLUPREDNATE (DIFLUPREDNATE)